A comparative review of use of sulphate and phosphate salts for colonoscopy preparations and their potential for nephrotoxicity

Abstract

Background and study aims Colonoscopy is a widely used diagnostic procedure which requires prior cleansing of the bowel. Many different bowel cleansing preparations have been developed, all of which have specific advantages and disadvantages. This review compares two low-volume high-osmolarity bowel cleansing preparations, oral phosphate salts and oral sulphate salts, with a particular focus on risk of nephrotoxicity.

Patients and methods An electronic search of the Medline database was performed using the search terms “(phosphates OR sulfates) AND cathartics [MeSH Term] AND kidney” restricted to humans with a cut-off date of December 31, 2016.

Results Introduction of oral phosphate salts offered the advantage of low intake volume and low risk of bowel irritation compared to previous options. However, phosphate salts have been associated with renal toxicity (acute phosphate nephropathy [APN]), thought to arise due to perturbations of calcium and phosphate homeostasis as a consequence of increases in serum phosphate. This results in high concentrations of calcium phosphate in the distal tubule and collecting ducts of the kidney, where it may precipitate. Although APN is rare, it may lead to permanent kidney damage. For this reason, phosphate salts are contraindicated in vulnerable patient groups. As an alternative to phosphate salts, oral sulphate salts have recently been introduced. Because sulphate absorption from the intestinal tract is saturable, serum sulphate concentrations increase only minimally after ingestion. Furthermore, excretion of sulphate in the kidney is not accompanied by calcium excretion and urine calcium levels are unchanged. For these theoretical reasons, use of sulphate salts as bowel cleansing solutions is not expected to lead to calcium precipitation in the nephron.

Conclusions Oral phosphate salts are no longer recommended for routine use as bowel cleansing preparations as they carry significant risk of kidney damage and a safer alternative is available in the form of oral sulphate solutions. To date, use of sulphate salts has not been associated with elevations in serum creatinine or other markers of renal impairment, nor with clinical manifestations of kidney injury. Nonetheless, experience with sulphate salts in everyday practice is limited and physicians should be vigilant in detecting potential safety issues.

• References

• 1 von Karsa L, Patnick J, Segnan N. et al. European guidelines for quality assurance in colorectal cancer screening and diagnosis: overview and introduction to the full supplement publication. Endoscopy 2013; 45: 51-59
• 2 Barkun A, Chiba N, Enns R. et al. Commonly used preparations for colonoscopy: efficacy, tolerability, and safety – a Canadian Association of Gastroenterology position paper. Can J Gastroenterol 2006; 20: 699-710
• 3 Belsey J, Epstein O, Heresbach D. Systematic review: oral bowel preparation for colonoscopy. Aliment Pharmacol Ther 2007; 25: 373-384
• 4 Wexner SD, Beck DE, Baron TH. et al. A consensus document on bowel preparation before colonoscopy: prepared by a task force from the American Society of Colon and Rectal Surgeons (ASCRS), the American Society for Gastrointestinal Endoscopy (ASGE), and the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES). Gastrointest Endosc 2006; 63: 894-909
• 5 Saltzman JR, Cash BD, Pasha SF. et al. Bowel preparation before colonoscopy. Gastrointest Endosc 2015; 81: 781-794
• 6 Hassan C, Bretthauer M, Kaminski MF. et al. Bowel preparation for colonoscopy: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy 2013; 45: 142-155
• 7 Fordtran JS, Hofmann AF. Seventy years of polyethylene glycols in gastroenterology: The journey of PEG 4000 and 3350 from nonabsorbable marker to colonoscopy preparation to osmotic laxative. Gastroenterology 2017; 152: 675-680
• 8 Ghandehari H, Smith PL, Ellens H. et al. Size-dependent permeability of hydrophilic probes across rabbit colonic epithelium. J Pharmacol Exp Ther 1997; 280: 747-753
• 9 Di Palma J, Rex D. Advances in bowel preparations: new formulation and clinical results. Gastroenterol Nurs 2011; 34 (Suppl. 02) S2-S8
• 10 Sabbagh Y, Giral H, Caldas Y. et al. Intestinal phosphate transport. Adv Chronic Kidney Dis 2011; 18: 85-90
• 11 Institute of Medicine. Dietary reference intakes for calcium, phosphorus, magnesium, vitamin D, and fluoride. The National Academies Press; 1997
• 12 Lederer E. Regulation of serum phosphate. The Journal of physiology 2014; 592: 3985-3995
• 13 Gumurdulu Y, Serin E, Ozer B. et al. Age as a predictor of hyperphosphatemia after oral phosphosoda administration for colon preparation. J Gastroenterol Hepatol 2004; 19: 68-72
• 14 Casais MN, Rosa-Diez G, Perez S. et al. Hyperphosphatemia after sodium phosphate laxatives in low risk patients: prospective study. World J Gastroenterol 2009; 15: 5960-5965
• 15 Lieberman DA, Ghormley J, Flora K. Effect of oral sodium phosphate colon preparation on serum electrolytes in patients with normal serum creatinine. Gastrointest Endosc 1996; 43: 467-469
• 16 Ehrenpreis ED. Increased serum phosphate levels and calcium fluxes are seen in smaller individuals after a single dose of sodium phosphate colon cleansing solution: a pharmacokinetic analysis. Aliment Pharmacol Ther 2009; 29: 1202-1211
• 17 DiPalma JA, Buckley SE, Warner BA. et al. Biochemical effects of oral sodium phosphate. Dig Dis Sci 1996; 41: 749-753
• 18 Caswell M, Thompson WO, Kanapka JA. et al. The time course and effect on serum electrolytes of oral sodium phosphates solution in healthy male and female volunteers. Can J Clin Pharmacol 2007; 14: e260-e274
• 19 Rex DK, Vanner SJ. Colon cleansing before colonoscopy: does oral sodium phosphate solution still make sense?. Can J Gastroenterol 2009; 23: 210-214
• 20 Florentin M, Liamis G, Elisaf MS. Colonoscopy preparation-induced disorders in renal function and electrolytes. World J Gastrointest Pharmacol Ther 2014; 5: 50-54
• 21 Clarkston WK, Tsen TN, Dies DF. et al. Oral sodium phosphate versus sulfate-free polyethylene glycol electrolyte lavage solution in outpatient preparation for colonoscopy: a prospective comparison. Gastrointest Endosc 1996; 43: 42-48
• 22 Beloosesky Y, Grinblat J, Weiss A. et al. Electrolyte disorders following oral sodium phosphate administration for bowel cleansing in elderly patients. Arch Intern Med 2003; 163: 803-808
• 23 Cocchetto DM, Levy G. Absorption of orally administered sodium sulfate in humans. J Pharm Sci 1981; 70: 331-333
• 24 Cole DE, Evrovski J. The clinical chemistry of inorganic sulfate. Crit Rev Clin Lab Sci 2000; 37: 299-344
• 25 Cole DE, Thurgood AM, Whiting SJ. Increased serum sulfate after protein loading in adult humans. Can J Physiol Pharmacol 1991; 69: 25-27
• 26 Hoffman DA, Wallace SM, Verbeeck RK. Circadian rhythm of serum sulfate levels in man and acetaminophen pharmacokinetics. Eur J Clin Pharmacol 1990; 39: 143-148
• 27 Pelham RW, Alcorn Jr H. et al. A pharmacokinetics evaluation of a new, low-volume, oral sulfate colon cleansing preparation in patients with renal or hepatic impairment and healthy volunteers. J Clin Pharmacol 2010; 50: 350-354
• 28 Di Palma JA, Rodriguez R, McGowan J. et al. A randomized clinical study evaluating the safety and efficacy of a new, reduced-volume, oral sulfate colon-cleansing preparation for colonoscopy. Am J Gastroenterol 2009; 104: 2275-2284
• 29 Rex DK, Di Palma JA, Rodriguez R. et al. A randomized clinical study comparing reduced-volume oral sulfate solution with standard 4-liter sulfate-free electrolyte lavage solution as preparation for colonoscopy. Gastrointest Endosc 2010; 72: 328-336
• 30 Anastassopoulos K, Farraye FA, Knight T. et al. A comparative study of treatment-emergent adverse events following use of common bowel preparations among a colonoscopy screening population: results from a post-marketing observational study. Dig Dis Sci 2016; 61: 2993-3006
• 31 Cheng CY, Kuro-o M, Razzaque MS. Molecular regulation of phosphate metabolism by fibroblast growth factor-23-klotho system. Adv Chronic Kidney Dis 2011; 18: 91-97
• 32 Mahon MJ. The parathyroid hormone receptorsome and the potential for therapeutic intervention. Curr Drug Targets 2012; 13: 116-128
• 33 Choi NW. Kidney and phosphate metabolism. Electrolyte Blood Press 2008; 6: 77-85
• 34 Hruska KA, Mathew S, Lund R. et al. Hyperphosphatemia of chronic kidney disease. Kidney Int 2008; 74: 148-157
• 35 Patel V, Nicar M, Emmett M. et al. Intestinal and renal effects of low-volume phosphate and sulfate cathartic solutions designed for cleansing the colon: pathophysiological studies in five normal subjects. Am J Gastroenterol 2009; 104: 953-965
• 36 Tan HL, Liew QY, Loo S. et al. Severe hyperphosphataemia and associated electrolyte and metabolic derangement following the administration of sodium phosphate for bowel preparation. Anaesthesia 2002; 57: 478-483
• 37 Murer H, Markovich D, Biber J. Renal and small intestinal sodium-dependent symporters of phosphate and sulphate. J Exp Biol 1994; 196: 167-181
• 38 Walser M, Browder AA. Ion association. III. The effect of sulfate infusion on calcium excretion. J Clin Invest 1959; 38: 1404-1411
• 39 Singh PP, Hussain F, Gupta RC. et al. Effect of dietary methionine and inorganic sulfate with and without calcium supplementation, on urinary calcium excretion of guinea pigs (Cavia porcellus). Indian J Exp Biol 1993; 31: 96-97
• 40 Zipser RD, Bischel MD, Abrams DE. Hypocalcemic tetany due to sodium phosphate ingestion in acute renal failure. Nephron 1975; 14: 378-381
• 41 Gonlusen G, Akgun H, Ertan A. et al. Renal failure and nephrocalcinosis associated with oral sodium phosphate bowel cleansing: clinical patterns and renal biopsy findings. Arch Pathol Lab Med 2006; 130: 101-106
• 42 Desmeules S, Bergeron MJ, Isenring P. Acute phosphate nephropathy and renal failure. N Engl J Med 2003; 349: 1006-1007
• 43 Markowitz GS, Nasr SH, Klein P. et al. Renal failure due to acute nephrocalcinosis following oral sodium phosphate bowel cleansing. Hum Pathol 2004; 35: 675-684
• 44 Markowitz GS, Whelan J, D’Agati VD. Renal failure following bowel cleansing with a sodium phosphate purgative. Nephrol Dial Transplant 2005; 20: 850-851
• 45 Weiss J, Thorp ML. Acute phosphate nephropathy: a cause of chronic kidney disease. BMJ Case Rep 2011; 3: 2011
• 46 Markowitz GS, Stokes MB, Radhakrishnan J. et al. Acute phosphate nephropathy following oral sodium phosphate bowel purgative: an underrecognized cause of chronic renal failure. J Am Soc Nephrol 2005; 16: 3389-3396
• 47 Harrison NM, Hjelkrem MC. Bowel cleansing before colonoscopy: Balancing efficacy, safety, cost and patient tolerance. World J Gastrointest Endosc 2016; 8: 4-12
• 48 Ehrenpreis ED, Parakkal D, Semer R. et al. Renal risks of sodium phosphate tablets for colonoscopy preparation: a review of adverse drug reactions reported to the US Food and Drug Administration. Colorectal Dis 2011; 13: e270-e275
• 49 Brunelli SM. Association between oral sodium phosphate bowel preparations and kidney injury: a systematic review and meta-analysis. Am J Kidney Dis 2009; 53: 448-456
• 50 Hurst FP, Bohen EM, Osgard EM. et al. Association of oral sodium phosphate purgative use with acute kidney injury. J Am Soc Nephrol 2007; 18: 3192-3198
• 51 Khurana A, McLean L, Atkinson S. et al. The effect of oral sodium phosphate drug products on renal function in adults undergoing bowel endoscopy. Arch Intern Med 2008; 168: 593-597
• 52 Singal AK, Rosman AS, Post JB. et al. The renal safety of bowel preparations for colonoscopy: a comparative study of oral sodium phosphate solution and polyethylene glycol. Aliment Pharmacol Ther 2008; 27: 41-47
• 53 Abaskharoun R, Depew W, Vanner S. Changes in renal function following administration of oral sodium phosphate or polyethylene glycol for colon cleansing before colonoscopy. Can J Gastroenterol 2007; 21: 227-231
• 54 Brunelli SM, Lewis JD, Gupta M. et al. Risk of kidney injury following oral phosphosoda bowel preparations. J Am Soc Nephrol 2007; 18: 3199-3205
• 55 Russmann S, Lamerato L, Marfatia A. et al. Risk of impaired renal function after colonoscopy: a cohort study in patients receiving either oral sodium phosphate or polyethylene glycol. Am J Gastroenterol 2007; 102: 2655-2663
• 56 Seol DC, Hong SN, Kim JH. et al. Change in renal function after sodium phosphate preparation for screening colonoscopy. World J Gastroenterol 2010; 16: 2010-2016
• 57 Layton JB, Klemmer PJ, Christiansen CF. et al. Sodium phosphate does not increase risk for acute kidney injury after routine colonoscopy, compared with polyethylene glycol. Clin Gastroenterol Hepatol 2014; 12: 1514-1521 e1513
• 58 Rex DK, DiPalma JA, McGowan J. et al. A comparison of oral sulfate solution with sodium picosulfate: magnesium citrate in split doses as bowel preparation for colonoscopy. Gastrointest Endosc 2014; 80: 1113-1123
• 59 Smith JM, Lowe RF, Fullerton J. et al. An integrative review of the side effects related to the use of magnesium sulfate for pre-eclampsia and eclampsia management. BMC Pregnancy Childbirth 2013; 13: 34
• 60 Hunter LA, Gibbins KJ. Magnesium sulfate: past, present, and future. J Midwifery Womens Health 2011; 56: 566-574